BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10274168)

  • 1. Modifying empiric antibiotic prescribing: experience with one strategy in a medical residency program.
    MacCosbe PE; Gartenberg G
    Hosp Formul; 1985 Sep; 20(9):986-8, 993-5, 999. PubMed ID: 10274168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach to cost-effective antibiotic utilization.
    Venezio FR; Waitley DW
    Hosp Formul; 1988 Dec; 23 Suppl D():32-5. PubMed ID: 10312796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a targeted antibiotic advisory consult program on hospital antibiotic costs.
    Murray MD; Kohler RB; Main JW
    Hosp Formul; 1988 Jun; 23(6):518-24, 529-30. PubMed ID: 10287850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent antibiotic-use review in a small hospital.
    Kerns MP; Meyer GE
    Am J Hosp Pharm; 1986 Jun; 43(6):1476-8. PubMed ID: 3728483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic use review using the "target drug" method.
    Puckett F; Baars R; Seay K
    Hosp Formul; 1987 May; 22(5):489-91. PubMed ID: 10281733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical committee enforcement of policy limiting postsurgical antibiotic use.
    Nickman NA; Blissenbach HF; Herrick JD
    Am J Hosp Pharm; 1984 Oct; 41(10):2053-6. PubMed ID: 6496494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial formulary management: a case study in a teaching hospital.
    Wright DB
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):27S-31S. PubMed ID: 2011570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach.
    Briceland LL; Nightingale CH; Quintiliani R; Cooper BW; Smith KS
    Arch Intern Med; 1988 Sep; 148(9):2019-22. PubMed ID: 3415406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic review: the experience of one pharmacy and therapeutics committee.
    Kiepert DR
    QRB Qual Rev Bull; 1979 Jan; 5(1):24-7. PubMed ID: 121376
    [No Abstract]   [Full Text] [Related]  

  • 14. P&T Committee antibiotic cost considerations.
    Rinehart JR
    Hosp Formul; 1986 Aug; 21(8):857-9, 862-4. PubMed ID: 10277580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in antibiotic use secondary to a small hospital antibiotic review.
    Strahl DA; Wightkin WT
    Hosp Formul; 1985 Mar; 20(3):310-2. PubMed ID: 10270306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-assisted antimicrobial-use monitoring.
    Inaraja MT; Paloma JM; Giráldez J; Idoate AJ; Hualde S
    Am J Hosp Pharm; 1986 Mar; 43(3):664-70. PubMed ID: 3754692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a selective restriction policy on antibiotic expenditure and use: an institutional model.
    Suwangool P; Moola-Or P; Waiwatana A; Sitthi-Amorn C; Israsena S; Hanvanich M
    J Med Assoc Thai; 1991 Jul; 74(7):272-5. PubMed ID: 1765742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Savings achieved through cephalosporin surveillance.
    Katz E; Schlamowitz S
    Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost containment through P & T committee drug utilization review.
    Bender FH; DeMatteo CS
    Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
    Cook AA; Sanchez ML
    Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.